First Advantage Co. (NYSE:FA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $58.67.
Several equities research analysts have recently issued reports on the company. Barclays decreased their price objective on First Advantage from $22.00 to $20.00 and set an “overweight” rating on the stock in a report on Friday, February 28th. Royal Bank of Canada restated an “outperform” rating and set a $22.00 price objective on shares of First Advantage in a report on Thursday, January 23rd. William Blair restated an “outperform” rating on shares of First Advantage in a report on Friday, February 28th. Finally, BMO Capital Markets decreased their price objective on First Advantage from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd.
Institutional Inflows and Outflows
First Advantage Price Performance
Shares of NYSE:FA opened at $13.45 on Wednesday. The business’s fifty day moving average price is $17.31 and its two-hundred day moving average price is $18.43. The stock has a market cap of $2.33 billion, a PE ratio of 448.33 and a beta of 1.21. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.85 and a current ratio of 3.85. First Advantage has a one year low of $12.55 and a one year high of $20.79.
First Advantage Company Profile
First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.
See Also
- Five stocks we like better than First Advantage
- 3 Monster Growth Stocks to Buy Now
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Profit From Growth Investing
- 3 Must-Own Stocks to Build Wealth This Decade
- What is the S&P 500 and How It is Distinct from Other Indexes
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for First Advantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Advantage and related companies with MarketBeat.com's FREE daily email newsletter.